Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Vij

Showing results (211-220 of 283) with videos related to

Pageof 29
Sort By:
Blood Cancer Journal|December 5, 2019
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood|July 27, 2012
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myelomaDavid S Siegel, Thomas Martin, Michael Wang, et al.
Blood|January 15, 2014
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 studyPaul G Richardson, David S Siegel, Ravi Vij, et al.
Blood Cancer Journal|April 30, 2021
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2008
Cancer- and chemotherapy-induced anemiaGeorge M Rodgers, Pamela Sue Becker, Charles L Bennett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myelomaRavi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2013
Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myelomaLuciano J Costa, Mei-Jie Zhang, Xiaobo Zhong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2015
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow TransplantationNina Shah, Natalie Callander, Siddhartha Ganguly, et al.
The Journal of Clinical Investigation|October 4, 2017
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia A Wagner, Maximillian Rosario, Rizwan Romee, et al.
Cell Reports|April 5, 2018
Driver Fusions and Their Implications in the Development and Treatment of Human CancersQingsong Gao, Wen-Wei Liang, Steven M Foltz, et al.
Pageof 29

Showing results (211-220 of 283) with videos related to

Sort By:
Pageof 29
Blood Cancer Journal|December 5, 2019
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood|July 27, 2012
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myelomaDavid S Siegel, Thomas Martin, Michael Wang, et al.
Blood|January 15, 2014
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 studyPaul G Richardson, David S Siegel, Ravi Vij, et al.
Blood Cancer Journal|April 30, 2021
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2008
Cancer- and chemotherapy-induced anemiaGeorge M Rodgers, Pamela Sue Becker, Charles L Bennett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myelomaRavi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2013
Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myelomaLuciano J Costa, Mei-Jie Zhang, Xiaobo Zhong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2015
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow TransplantationNina Shah, Natalie Callander, Siddhartha Ganguly, et al.
The Journal of Clinical Investigation|October 4, 2017
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia A Wagner, Maximillian Rosario, Rizwan Romee, et al.
Cell Reports|April 5, 2018
Driver Fusions and Their Implications in the Development and Treatment of Human CancersQingsong Gao, Wen-Wei Liang, Steven M Foltz, et al.
Pageof 29